| 27/08/24 | 07:00:12 | 27 Aug 2024 | | Update on funding | RNS |
| 22/07/24 | 07:01:00 | 22 Jul 2024 | | Trading update for the year ended 30 June 2024 | RNS |
| 22/07/24 | 07:00:10 | 22 Jul 2024 | | Appointment of Nominated Adviser and Sole Broker | RNS |
| 04/07/24 | 14:22:06 | 4 Jul 2024 | | Launch of new Company Long Term Incentive Plan | RNS |
| 27/06/24 | 07:00:14 | 27 Jun 2024 | | Appointment of Non-Executive Director | RNS |
| 10/06/24 | 07:00:07 | 10 Jun 2024 | | Progression of patient cohorts in PROTECT Trial | RNS |
| 03/06/24 | 07:00:09 | 3 Jun 2024 | | Successful meetings with Paul Ehrlich Institut | RNS |
| 31/05/24 | 07:00:13 | 31 May 2024 | | Allergy Therapeutics presents findings at EAACI | RNS |
| 07/05/24 | 07:00:15 | 7 May 2024 | | Further detail from G306 Phase III field trial | RNS |
| 03/04/24 | 07:00:10 | 3 Apr 2024 | | Director Resignation | RNS |
| 27/03/24 | 07:00:08 | 27 Mar 2024 | | Update on funding | RNS |
| 27/03/24 | 07:00:08 | 27 Mar 2024 | | Interim Results for six months ended 31 Dec 2023 | RNS |
| 12/03/24 | 08:59:47 | 12 Mar 2024 | | VLP Peanut PROTECT Trial Update | RNS |
| 12/03/24 | 07:00:10 | 12 Mar 2024 | | VLP Peanut PROTECT Trial Update | RNS |
| 11/03/24 | 07:00:06 | 11 Mar 2024 | | Appointment of Shaun Furlong to Board of Directors | RNS |
| 08/03/24 | 13:49:47 | 8 Mar 2024 | | Result of AGM | RNS |
| 14/02/24 | 07:00:04 | 14 Feb 2024 | | Half-Year Trading Update 2024 | RNS |
| 09/02/24 | 15:07:26 | 9 Feb 2024 | | Notice of 2023 Annual General Meeting | RNS |
| 30/01/24 | 07:00:08 | 30 Jan 2024 | | Publication of Annual Report and Accounts 2023 | RNS |
| 04/01/24 | 12:29:17 | 4 Jan 2024 | | Total Voting Rights | RNS |
| 27/12/23 | 12:01:20 | 27 Dec 2023 | | Amendment to existing Facility Agreement | RNS |
| 15/12/23 | 12:48:37 | 15 Dec 2023 | | Annual Report and Accounts Delayed | RNS |
| 13/12/23 | 16:54:47 | 13 Dec 2023 | | PDMR dealing and Total Voting Rights | RNS |
| 13/12/23 | 07:00:13 | 13 Dec 2023 | | G306 Phase III trial meets key endpoints | RNS |
| 11/12/23 | 07:00:09 | 11 Dec 2023 | | Update on funding | RNS |
| 01/12/23 | 07:00:08 | 1 Dec 2023 | | Total Voting Rights | RNS |
| 28/11/23 | 15:03:01 | 28 Nov 2023 | | Holding(s) in Company | RNS |
| 14/11/23 | 07:00:12 | 14 Nov 2023 | | G306 Grass Phase III trial meets primary endpoint | RNS |
| 10/11/23 | 13:22:01 | 10 Nov 2023 | | Director/PCA Dealing | RNS |
| 10/11/23 | 13:11:49 | 10 Nov 2023 | | Holding(s) in Company | RNS |
| 09/11/23 | 10:48:33 | 9 Nov 2023 | | Exercise of Options and Total Voting Rights | RNS |
| 06/11/23 | 07:00:14 | 6 Nov 2023 | | Update on funding | RNS |
| 20/10/23 | 17:17:10 | 20 Oct 2023 | | Holding(s) in Company | RNS |
| 16/10/23 | 17:39:30 | 16 Oct 2023 | | Southern Fox: Form 8.3 – Allergy Therapeutics Plc | RNS |
| 16/10/23 | 15:03:13 | 16 Oct 2023 | | Holding(s) in Company | RNS |
| 13/10/23 | 07:00:11 | 13 Oct 2023 | | Result of Open Offer and Subscription | RNS |
| 02/10/23 | 17:53:41 | 2 Oct 2023 | | Block Listing Interim Review | RNS |
| 27/09/23 | 12:04:15 | 27 Sept 2023 | | Publication of Open Offer Circular – Amendment | RNS |
| 27/09/23 | 07:01:02 | 27 Sept 2023 | | Publication of Open Offer Circular | RNS |
| 27/09/23 | 07:00:08 | 27 Sept 2023 | | Unaudited Preliminary Results 2023 | RNS |
| 26/09/23 | 07:00:06 | 26 Sept 2023 | | Phase I VLP Peanut PROTECT trial progress | RNS |
| 22/09/23 | 07:00:04 | 22 Sept 2023 | | Satisfaction of FDI clearance conditions | RNS |
| 10/08/23 | 07:00:03 | 10 Aug 2023 | | Trading update for the year ended 30 June 2023 | RNS |
| 31/07/23 | 14:33:58 | 31 Jul 2023 | | Result of General Meeting | RNS |
| 10/07/23 | 13:12:51 | 10 Jul 2023 | | Appointment of Chief Financial Officer | RNS |
| 19/06/23 | 07:01:02 | 19 Jun 2023 | | Interim Results and Lifting Suspension in Trading | RNS |
| 19/06/23 | 07:00:04 | 19 Jun 2023 | | Publication of Annual Report and Accounts 2022 | RNS |
| 09/06/23 | 07:00:06 | 9 Jun 2023 | | Allergy Therapeutics shares key findings at EAACI | RNS |
| 27/04/23 | 14:15:06 | 27 Apr 2023 | | Result of General Meeting | RNS |
| 24/04/23 | 07:00:07 | 24 Apr 2023 | | Southern Fox: Form 8.3 – Allergy Therapeutics Plc | RNS |
